DC-SIGN mediated sphingomyelinase-activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells

PLoS Pathogens

Volumn 7, Issue 2, 2011, Pages

  Avota, Elita ^a   Gulbins, Erich ^b   Schneider Schaulies, Sibylle ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; CD209 ANTIGEN; CERAMIDE; MANNAN; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN; LEUKOCYTE ANTIGEN; MESSENGER RNA; SMALL INTERFERING RNA; VIRUS RECEPTOR;

ARTICLE; CELL MEMBRANE; CELL SURFACE; CELLULAR IMMUNITY; DENDRITIC CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MEASLES VIRUS; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS INFECTION; ANTIGEN PRESENTATION; CELL CULTURE; DRUG ANTAGONISM; FLOW CYTOMETRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; IMMUNOPRECIPITATION; MEASLES; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; WESTERN BLOTTING;

MEASLES VIRUS;

ANTIGEN PRESENTATION; ANTIGENS, CD; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELLS, CULTURED; CERAMIDES; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; LECTINS, C-TYPE; MEASLES; MEASLES VIRUS; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SPHINGOMYELIN PHOSPHODIESTERASE; T-LYMPHOCYTES;

EID: 79952206109     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001290     Document Type: Article

References (68)

1. Freer G, Matteucci D, (2009) Influence of dendritic cells on viral pathogenicity. PLoS Pathog 5: e1000384.
2. Servet-Delprat C, Vidalain PO, Valentin H, Rabourdin-Combe C, (2003) Measles virus and dendritic cell functions: how specific response cohabits with immunosuppression. Curr Top Microbiol Immunol 276: 103-123.
3. Pohl C, Shishkova J, Schneider-Schaulies S, (2007) Viruses and dendritic cells: enemy mine. Cell Microbiol 9: 279-289.
4. Schneider-Schaulies S, Klagge IM, ter Meulen V, (2003) Dendritic cells and measles virus infection. Curr Top Microbiol Immunol 276: 77-101.
5. Veillette A, Cruz-Munoz ME, Zhong MC, (2006) SLAM family receptors and SAP-related adaptors: matters arising. Trends Immunol 27: 228-234.
6. de Swart RL, Ludlow M, de Witte L, Yanagi Y, van Amerongen G, et al. (2007) Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3: e178.
7. Kruse M, Meinl E, Henning G, Kuhnt C, Berchtold S, et al. (2001) Signaling lymphocytic activation molecule is expressed on mature CD83+ dendritic cells and is up-regulated by IL-1 beta. J Immunol 167: 1989-1995.
8. Schneider-Schaulies J, Schneider-Schaulies S, (2008) Receptor interactions, tropism, and mechanisms involved in morbillivirus-induced immunomodulation. Adv Virus Res 71: 173-205.
9. de Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TB, (2006) Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 80: 3477-3486.
10. de Witte L, de Vries RD, van der Vlist M, Yuksel S, Litjens M, et al. (2008) DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog 4: e1000049.
11. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, et al. (2007) C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26: 605-616.
12. Geijtenbeek TB, van Kooyk Y, (2003) Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity. APMIS 111: 698-714.
13. van Kooyk Y, Geijtenbeek TB, (2003) DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3: 697-709.
14. Bleijs DA, Geijtenbeek TB, Figdor CG, van Kooyk Y, (2001) DC-SIGN and LFA-1: a battle for ligand. Trends Immunol 22: 457-463.
15. Garcia-Vallejo JJ, van Kooyk Y, (2009) Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis. Immunol Rev 230: 22-37.
16. Neumann AK, Thompson NL, Jacobson K, (2008) Distribution and lateral mobility of DC-SIGN on immature dendritic cells-implications for pathogen uptake. J Cell Sci 121: 634-643.
17. Cambi A, de Lange F, van Maarseveen NM, Nijhuis M, Joosten B, et al. (2004) Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J Cell Biol 164: 145-155.
18. Cambi A, Lidke DS, Arndt-Jovin DJ, Figdor CG, Jovin TM, (2007) Ligand-conjugated quantum dots monitor antigen uptake and processing by dendritic cells. Nano Lett 7: 970-977.
19. de Bakker BI, de Lange F, Cambi A, Korterik JP, van Dijk EM, et al. (2007) Nanoscale organization of the pathogen receptor DC-SIGN mapped by single-molecule high-resolution fluorescence microscopy. Chemphyschem 8: 1473-1480.
20. den Dunnen J, Gringhuis SI, Geijtenbeek TB, (2009) Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother 58: 1149-1157.
21. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB, (2009) Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol 10: 1081-1088.
22. Hodges A, Sharrocks K, Edelmann M, Baban D, Moris A, et al. (2007) Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat Immunol 8: 569-577.
23. Ludwig IS, Lekkerkerker AN, Depla E, Bosman F, Musters RJ, et al. (2004) Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J Virol 78: 8322-8332.
24. de Witte L, Nabatov A, Geijtenbeek TB, (2008) Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol Med 14: 12-19.
25. Marzi A, Moller P, Hanna SL, Harrer T, Eisemann J, et al. (2007) Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR. J Infect Dis 196: S237-246.
26. Hannun YA, Luberto C, (2000) Ceramide in the eukaryotic stress response. Trends Cell Biol 10: 73-80.
27. Zhang Y, Li X, Becker KA, Gulbins E, (2009) Ceramide-enriched membrane domains-Structure and function. Biochim Biophys Acta 1788: 178-83.
28. Grassme H, Riethmuller J, Gulbins E, (2007) Biological aspects of ceramide-enriched membrane domains. Prog Lipid Res 46: 161-170.
29. Schenck M, Carpinteiro A, Grassme H, Lang F, Gulbins E, (2007) Ceramide: physiological and pathophysiological aspects. Arch Biochem Biophys 462: 171-175.
30. Hannun YA, Obeid LM, (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139-150.
31. Clarke CJ, Snook CF, Tani M, Matmati N, Marchesini N, et al. (2006) The extended family of neutral sphingomyelinases. Biochemistry 45: 11247-11256.
32. Goni FM, Alonso A, (2002) Sphingomyelinases: enzymology and membrane activity. FEBS Lett 531: 38-46.
33. Yin X, Zafrullah M, Lee H, Haimovitz-Friedman A, Fuks Z, et al. (2009) A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation. Cell Physiol Biochem 24: 219-230.
34. Zafrullah M, Yin X, Haimovitz-Friedman A, Fuks Z, Kolesnick R, (2009) Kinase suppressor of Ras transphosphorylates c-Raf-1. Biochem Biophys Res Commun 390: 434-440.
35. Ruvolo PP, (2003) Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res 47: 383-392.
36. Zhang Y, Yao B, Delikat S, Bayoumy S, Lin XH, et al. (1997) Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89: 63-72.
37. Yan F, Polk DB, (2001) Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells. Cancer Res 61: 963-969.
38. Becker KA, Gellhaus A, Winterhager E, Gulbins E, (2008) Ceramide-enriched membrane domains in infectious biology and development. Subcell Biochem 49: 523-538.
39. Gulbins E, Dreschers S, Wilker B, Grassme H, (2004) Ceramide, membrane rafts and infections. J Mol Med 82: 357-363.
40. Utermohlen O, Herz J, Schramm M, Kronke M, (2008) Fusogenicity of membranes: the impact of acid sphingomyelinase on innate immune responses. Immunobiology 213: 307-314.
41. Caparros E, Munoz P, Sierra-Filardi E, Serrano-Gomez D, Puig-Kroger A, et al. (2006) DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 107: 3950-3958.
42. Fadeel B, Gleiss B, Hogstrand K, Chandra J, Wiedmer T, et al. (1999) Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem Biophys Res Commun 266: 504-511.
43. Cambi A, Beeren I, Joosten B, Fransen JA, Figdor CG, (2009) The C-type lectin DC-SIGN internalizes soluble antigens and HIV-1 virions via a clathrin-dependent mechanism. Eur J Immunol 39: 1923-1928.
44. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
45. Geijtenbeek TB, van Kooyk Y, (2003) DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission. Curr Top Microbiol Immunol 276: 31-54.
46. Halary F, Amara A, Lortat-Jacob H, Messerle M, Delaunay T, et al. (2002) Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17: 653-664.
47. Huwiler A, Brunner J, Hummel R, Vervoordeldonk M, Stabel S, et al. (1996) Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci U S A 93: 6959-6963.
48. Yao B, Zhang Y, Delikat S, Mathias S, Basu S, et al. (1995) Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378: 307-310.
49. Rozenova KA, Deevska GM, Karakashian AA, Nikolova-Karakashian MN, (2010) Studies on the role of acid sphingomyelinase and ceramide in the regulation of TACE activity and TNFα secretion in macrophages. J Biol Chem 285: 21103-13.
50. Gassert E, Avota E, Harms H, Krohne G, Gulbins E, et al. (2009) Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression. PLoS Pathog 5: e1000623.
51. Mathias S, Younes A, Kan CC, Orlow I, Joseph C, et al. (1993) Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 259: 519-522.
52. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, et al. (1996) FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86: 937-947.
53. Hashiguchi T, Maenaka K, Yanagi Y, (2008) X-ray crystallographic analysis of measles virus hemagglutinin. Uirusu 58: 1-10.
54. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, et al. (2002) Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 76: 8729-8736.
55. Minagawa H, Tanaka K, Ono N, Tatsuo H, Yanagi Y, (2001) Induction of the measles virus receptor SLAM (CD150) on monocytes. J Gen Virol 82: 2913-2917.
56. Falcone S, Perrotta C, De Palma C, Pisconti A, Sciorati C, et al. (2004) Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3′,5′-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells. J Immunol 173: 4452-4463.
57. Sallusto F, Nicolo C, De Maria R, Corinti S, Testi R, (1996) Ceramide inhibits antigen uptake and presentation by dendritic cells. J Exp Med 184: 2411-2416.
58. Franchi L, Malisan F, Tomassini B, Testi R, (2006) Ceramide catabolism critically controls survival of human dendritic cells. J Leukoc Biol 79: 166-172.
59. MacKichan ML, DeFranco AL, (1999) Role of ceramide in lipopolysaccharide (LPS)-induced signaling. LPS increases ceramide rather than acting as a structural homolog. J Biol Chem 274: 1767-1775.
60. Rotolo JA, Zhang J, Donepudi M, Lee H, Fuks Z, et al. (2005) Caspase-dependent and-independent activation of acid sphingomyelinase signaling. J Biol Chem 280: 26425-26434.
61. Ohgimoto S, Ohgimoto K, Niewiesk S, Klagge IM, Pfeuffer J, et al. (2001) The haemagglutinin protein is an important determinant of measles virus tropism for dendritic cells in vitro. J Gen Virol 82: 1835-1844.
62. Finnegan CM, Blumenthal R, (2006) Fenretinide inhibits HIV infection by promoting viral endocytosis. Antiviral Res 69: 116-123.
63. Finnegan CM, Rawat SS, Cho EH, Guiffre DL, Lockett S, et al. (2007) Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. J Virol 81: 5294-5304.
64. Jacobs A, Garg H, Viard M, Raviv Y, Puri A, et al. (2008) HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development. Vaccine 26: 3026-3035.
65. Berger SB, Romero X, Ma C, Wang G, Faubion WA, et al. (2010) SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages. Nat Immunol 11: 920-927.
66. Spielhofer P, Bachi T, Fehr T, Christiansen G, Cattaneo R, et al. (1998) Chimeric measles viruses with a foreign envelope. J Virol 72: 2150-2159.
67. Korzeniowski M, Shakor AB, Makowska A, Drzewiecka A, Bielawska A, et al. (2007) Fc gamma RII activation induces cell surface ceramide production which participates in the assembly of the receptor signaling complex. Cell Physiol Biochem 20: 347-356.
68. Tellier E, Negre-Salvayre A, Bocquet B, Itohara S, Hannun YA, et al. (2007) Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. Mol Cell Biol 27: 2997-3007.